Initial ribociclib plus endocrine therapy for HR+/HER2- advanced breast cancer in pre- and postmenopausal Chinese women: Primary results from a phase 2 randomized study.

Zhimin ShaoZhongsheng TongQiang LiuWei LiLi CaiKunwei ShenHuiping LiChuan WangJin YangZhenchuan SongShui WangTing LuoWenhe ZhaoHaibo WangYueyin PanJianyun NieXiaohua ZengYanqing BaiWendy ChiangValeria GuarnacciaYu BiBinghe Xu

Published in: Cancer medicine (2024)

Keyphrases

breast cancer risk
polycystic ovary syndrome
bone mineral density
pregnancy outcomes
type diabetes
insulin resistance
metabolic syndrome
adipose tissue
young adults
body composition
childhood cancer